Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: waning and association with self‐reported severity and duration of illness-Reference-Cited by-同舟云学术

Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: waning and association with self‐reported severity and duration of illness

Published:2018-12-09 Issue: Volume: Page:
ISSN:1750-2640
Container-title:Influenza and Other Respiratory Viruses
language:en
Short-container-title:Influenza Other Respi Viruses

Author:

Tunheim Gro¹²,Laake Ida¹,Robertson Anna Hayman¹,Waalen Kristian¹,Hungnes Olav¹,Næss Lisbeth M.¹,Cox Rebecca J.²³⁴,Mjaaland Siri¹²,Trogstad Lill¹

Affiliation:

1. Division of Infection Control and Environmental Health Norwegian Institute of Public Health 0213 OsloNorway

2. K. G. Jebsen Centre for Influenza Vaccine Research University of Oslo 0424 OsloNorway

3. The Influenza Centre Department of Clinical Science University of Bergen 5021 BergenNorway

4. Department of Research and Development Haukeland University Hospital N5021 Bergen Norway

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/irv.12623

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody response and its persistence to an inactivated SARS-CoV-2 virus vaccine in young Bangladeshi adults: a prospective study;IMC Journal of Medical Science;2024-09-02

2. Risk factors for SARS-CoV-2 infection: a test-negative case–control study with additional population controls in Norway;BMJ Open;2024-01

3. Transplacental transfer efficiency of maternal antibodies against influenza A(H1N1)pdm09 virus and dynamics of naturally acquired antibodies in Chinese children: a longitudinal, paired mother–neonate cohort study;The Lancet Microbe;2023-11

4. Risk factors for SARS-CoV-2 infection: A test-negative case-control study with additional population controls;2023-03-19

5. SARS-CoV-2 antibody persistence after five and twelve months: A cohort study from South-Eastern Norway;PLOS ONE;2022-08-10